Zapalenie oskrzeli
Epidemiologia

Zapalenie oskrzeli, zarówno ostre, jak i przewlekłe, stanowi istotny problem zdrowia publicznego o zróżnicowanej epidemiologii zależnej od wieku, czynników środowiskowych i demograficznych. Ostre zapalenie oskrzeli dotyka około 5% dorosłych rocznie w USA oraz 54 przypadki na 1000 osób w Wielkiej Brytanii, z wyraźną sezonowością – 82% przypadków występuje jesienią i zimą, głównie u dzieci poniżej 5 roku życia. Przewlekłe zapalenie oskrzeli dotyka 3-22% populacji światowej, a w USA 3,6-4,6% dorosłych (9-14 mln osób), z wyższą częstością u kobiet (6,7% vs 5,2% u mężczyzn) i osób w wieku 44-65 lat. Kluczowymi czynnikami ryzyka są palenie tytoniu, zanieczyszczenie powietrza, astma, starszy wiek oraz ekspozycja zawodowa na pyły i opary. Wskaźniki umieralności z powodu przewlekłego zapalenia oskrzeli u mężczyzn zmniejszyły się w latach 1999-2014, podczas gdy u kobiet pozostały stabilne. Zanieczyszczenie powietrza, zwłaszcza w regionach o dużym natężeniu ruchu i w okresie zimowym, znacząco nasila objawy chorób układu oddechowego, co potwierdzają obserwacje z Indii i Południowej Kalifornii.

Epidemiologia zapalenia oskrzeli

Zapalenie oskrzeli jest jedną z najbardziej powszechnych chorób układu oddechowego na świecie, stanowiącą istotny problem zdrowia publicznego. Epidemiologia tego schorzenia różni się w zależności od typu (ostre lub przewlekłe), czynników demograficznych oraz geograficznych.12

Epidemiologia ostrego zapalenia oskrzeli

Ostre zapalenie oskrzeli dotyka około 5% dorosłych rocznie w Stanach Zjednoczonych, stanowiąc jedną z najczęstszych przyczyn wizyt ambulatoryjnych. Według danych z Wielkiej Brytanii, częstość występowania tego schorzenia wynosi około 54 przypadki na 1000 osób, co daje podobny wskaźnik do danych amerykańskich.12

Częstość występowania ostrego zapalenia oskrzeli wykazuje znaczną sezonowość – szczyt zachorowań przypada na miesiące zimowe, co zbiega się z sezonowym wzrostem częstości wirusowych infekcji dróg oddechowych, takich jak grypa i RSV (syncytialny wirus oddechowy).13 W jednym z badań wykazano, że 82% przypadków ostrego zapalenia oskrzeli występuje jesienią lub zimą.4

Ostre zapalenie oskrzeli jest częstsze u dzieci poniżej 5 roku życia, stanowiąc jedną z głównych przyczyn hospitalizacji w oddziałach ratunkowych. U niemowląt poniżej pierwszego roku życia stanowi najczęstszą przyczynę przyjęć do szpitala po wizycie na oddziale ratunkowym w USA.567

Częstość występowania ostrego zapalenia oskrzeli różni się w zależności od wieku, przy czym wskaźniki są niższe wśród młodszych mężczyzn (36 na 1000) i wyższe wśród osób powyżej 85 roku życia (225 na 1000).1 W populacji dziecięcej w Wielkiej Brytanii zgłaszana częstość występowania zapalenia oskrzeli wynosi około 20,7%.8

Cechy demograficzne nie wykazują szczególnych różnic w częstości występowania ostrego zapalenia oskrzeli między płciami – dotyka ono zarówno mężczyzn, jak i kobiety w równym stopniu. Nie stwierdzono również preferencji rasowych.29

Epidemiologia przewlekłego zapalenia oskrzeli

Przewlekłe zapalenie oskrzeli stanowi jedną z najczęstszych przyczyn przewlekłego kaszlu. Dotyka 3-22% populacji światowej i średnio 27-35% osób z przewlekłą obturacyjną chorobą płuc (POChP).1

W Stanach Zjednoczonych przewlekłe zapalenie oskrzeli dotyka około 9-14 milionów osób rocznie, co stanowi około 3,6-4,6% populacji dorosłych.23 Większość przypadków dotyczy osób w wieku 44-65 lat, choć 31% chorych stanowią osoby między 18 a 44 rokiem życia.1

Obserwuje się spadek częstości występowania przewlekłego zapalenia oskrzeli – w latach 1999-2018 wskaźniki zmniejszyły się średnio o 1,5 punktu procentowego rocznie.2

Czynniki demograficzne związane z wyższą częstością występowania przewlekłego zapalenia oskrzeli u dorosłych to:14

  • Palenie tytoniu
  • Starszy wiek
  • Zwiększona ciężkość POChP
  • Płeć żeńska
  • Astma
  • Obturacyjny bezdech senny
  • Przynależność do populacji nie-latynoskiej czarnej i białej

1

W przeciwieństwie do ostrego zapalenia oskrzeli, przewlekłe zapalenie oskrzeli występuje częściej u kobiet niż u mężczyzn (6,7% w porównaniu do 5,2%). Wskaźniki umieralności skorygowane o wiek u mężczyzn zmniejszyły się w latach 1999-2014, ale pozostały stabilne wśród kobiet.4

Występują różnice rasowe w częstości występowania przewlekłego zapalenia oskrzeli – Latynosi rzadziej zgłaszają POChP niż nie-latynoscy biali i czarni (4,0% w porównaniu do odpowiednio 6,3% i 6,1%). Wskaźniki śmiertelności są wyższe wśród białych niż wśród czarnych lub osób wszystkich innych ras.4

Czynniki ryzyka zapalenia oskrzeli

Kilka istotnych czynników ryzyka przyczynia się do rozwoju zarówno ostrego, jak i przewlekłego zapalenia oskrzeli:12

  • Palenie tytoniu – główny czynnik ryzyka dla przewlekłego zapalenia oskrzeli, choć istnieje 4-22% szans, że niepalący również mogą zachorować
  • Zanieczyszczenie powietrza – życie w obszarach o wysokim zanieczyszczeniu powietrza zwiększa ryzyko
  • Zatłoczone warunki mieszkaniowe – sprzyjają przenoszeniu patogenów dróg oddechowych
  • Historia astmy – zwiększa podatność na zapalenie oskrzeli
  • Wiek – osoby starsze (powyżej 45 lat) są bardziej narażone, szczególnie na przewlekłe zapalenie oskrzeli
  • Specyficzne alergeny – pyłki, perfumy i opary mogą potencjalnie wywołać ostre zapalenie oskrzeli u podatnych osób
  • Ekspozycja na opary, pyły i dymy – szczególnie w środowisku zawodowym
  • Czynniki genetyczne – mogą zwiększać podatność na zapalenie oskrzeli

123

Wpływ czynników środowiskowych

Zanieczyszczenie powietrza jest znaczącym globalnym problemem zdrowotnym ze względu na jego wpływ na zdrowie układu oddechowego, w tym na rozwój zapalenia oskrzeli. Zanieczyszczenia takie jak pył zawieszony (PM), dwutlenek azotu (NO₂), dwutlenek siarki (SO₂), ozon (O₃), tlenek węgla (CO) i lotne związki organiczne (VOC) szkodzą układowi oddechowemu, powodując podrażnienia, stany zapalne i uszkodzenia dróg oddechowych oraz tkanek płucnych.3

W Indiach, szczególnie w miesiącach zimowych od listopada do lutego, gabinety lekarzy rodzinnych i pulmonologów są przepełnione przypadkami infekcji dróg oddechowych, a połowa z nich jest wtórna do alergii na roztocza kurzu. Większość takich przypadków pochodzi z gospodarstw domowych mieszkających w pobliżu dróg o dużym natężeniu ruchu i wysokim stężeniu cząstek pyłu w powietrzu oraz z gospodarstw domowych mieszkających w pobliżu placów budowy.4

Pogarszająca się jakość powietrza w Delhi podczas sezonu zimowego powoduje wzrost liczby przypadków dyskomfortu oddechowego. Pacjenci zgłaszają ostre objawy astmy i przewlekłej obturacyjnej choroby płuc (POChP), takie jak świszczący oddech, duszność i silny kaszel. Według kierownika Wydziału Pulmonologii w AIIMS, nastąpił 10-15% wzrost liczby pacjentów z pogarszającymi się objawami w porównaniu do normalnej sytuacji.5

Badanie przeprowadzone przez Berhane i wsp. wykazało, że w wyniku poprawy jakości powietrza atmosferycznego w Południowej Kalifornii, objawy zapalenia oskrzeli zmniejszyły się u dzieci z tego regionu w latach 1993-2012.6

Nadzór i monitorowanie zapalenia oskrzeli

Systemy nadzoru nad chorobami układu oddechowego, w tym zapaleniem oskrzeli, są kluczowe dla zrozumienia wzorców epidemiologicznych i opracowania skutecznych strategii interwencyjnych. Narodowy System Nadzoru nad Wirusami Układu Oddechowego i Jelitowego (NREVSS) w USA jest systemem laboratoryjnym, który monitoruje aktywność wirusów układu oddechowego.1

NREVSS umożliwia terminową analizę danych w celu monitorowania sezonów wirusowych i wzorców cyrkulacji. System ten odgrywa ważną rolę w opisywaniu czasowych i geograficznych wzorców cyrkulacji wirusów układu oddechowego, w tym zmian w typowych rocznych wzorcach cyrkulacji i identyfikacji ognisk wirusowych.1

W Wielkiej Brytanii monitorowanie trendów w codziennych zgłoszeniach na oddziały ratunkowe może zapewnić wczesne ostrzeżenie o zagrożeniach dla zdrowia publicznego i dostarczyć szczegółowych informacji do działań w zakresie zdrowia publicznego. Wskaźnik pokazuje 7-dniową średnią ruchomą dziennej liczby przyjęć na oddziały ratunkowe osób ze zdiagnozowanym ostrym zapaleniem oskrzelików lub oskrzeli.2

Badania epidemiologiczne i międzynarodowe porównania

Globalne badania epidemiologiczne dostarczają cennych informacji na temat różnic w częstości występowania zapalenia oskrzeli w różnych regionach świata. W Europie przeprowadzono obszerne badanie przez Europejską Wspólnotę Węgla i Stali (ECSC) między 1970 a 1976 rokiem we wszystkich krajach członkowskich EWG, porównujące konsekwencje przewlekłego zapalenia oskrzeli wśród pracowników przemysłu stalowego i węglowego z pracownikami innych sektorów przemysłu.1

W Szwecji, badanie kwestionariuszowe dotyczące objawów i chorób układu oddechowego wypełnione przez 6610 dorosłych w 3 kohortach wiekowych (35-36 lat; 50-51 lat i 65-66 lat) w północnej Szwecji, zostało uzupełnione wywiadem i badaniem czynności płuc 1243 osób z objawami astmatycznymi lub zapalenia oskrzeli i 263 osób ocenionych na podstawie kwestionariusza pocztowego jako zdrowe. Według zastosowanych kryteriów, u 292 osób (5,1% oryginalnej próby badawczej) zdiagnozowano astmę. Spośród 1243 osób u 334 (5,9% oryginalnej populacji badanej) zdiagnozowano przewlekłe zapalenie oskrzeli. Jednak badanie 263 osób, które według kwestionariusza pocztowego były zdrowe, wykazało, że starsi palacze, w szczególności, nie zgłaszali objawów zapalenia oskrzeli; biorąc to pod uwagę, częstość występowania przewlekłego zapalenia oskrzeli szacuje się na około 9%.2

W Indiach przeprowadzono badanie epidemiologii astmy, objawów oddechowych i przewlekłego zapalenia oskrzeli (INSEARCH) w dwóch fazach. Faza II, która miała miejsce w latach 2007-2009, obejmowała badanie przeprowadzone w dwunastu ośrodkach badawczych w całych Indiach. W ramach tego badania przeprowadzono wywiady z łączną próbą 169 575 osób; uczestnicy pochodzili z obszarów wiejskich i miejskich dla wszystkich ośrodków z wyjątkiem Secunderabad, który obejmował tylko obszary miejskie.3

Region Ostre zapalenie oskrzeli Przewlekłe zapalenie oskrzeli Główne czynniki ryzyka
Stany Zjednoczone 5% dorosłych rocznie 3,6-4,6% dorosłych (9-14 mln osób) Palenie tytoniu, zanieczyszczenie powietrza, astma
Wielka Brytania 54 przypadki na 1000 osób 1 na 59 osób (842,100 z 50 mln) Status socjoekonomiczny, palenie tytoniu
Indie Dane niepełne Dane z badania INSEARCH (2007-2009) Zanieczyszczenie powietrza, pyły, smog
Szwecja Dane niepełne Około 9% populacji Palenie tytoniu, wiek
Niemcy 28% dzieci Dane niepełne Infekcje dolnych dróg oddechowych

Nadużywanie antybiotyków i problemy diagnostyczne

Istotnym problemem związanym z epidemiologią zapalenia oskrzeli jest nadużywanie antybiotyków w leczeniu ostrego zapalenia oskrzeli. Ponad 10 milionów osób w USA odwiedza rocznie lekarza z powodu tego schorzenia, przy czym około 70% otrzymuje antybiotyki, które w większości są niepotrzebne.12

Jednym z powodów, dla których ostre zapalenie oskrzeli jest tak częstą diagnozą w podstawowej opiece zdrowotnej, jest to, że lekarze często grupują różne stany pod diagnozą zapalenia oskrzeli. Przy braku wyraźnych objawów diagnostycznych lub testów laboratoryjnych, diagnoza ostrego zapalenia oskrzeli jest czysto kliniczna. W konsekwencji kaszel z infekcji górnych dróg oddechowych, zapalenia zatok lub zespołów alergicznych (np. łagodna astma lub wirusowe zapalenie płuc) może być diagnozowany jako ostre zapalenie oskrzeli.3

Sugerowano również nadmierną diagnozę przewlekłego zapalenia oskrzeli przez pacjentów i klinicystów. Termin „zapalenie oskrzeli” jest często używany jako powszechny określnik niespecyficznego i samoograniczającego się kaszlu, tym samym fałszywie zwiększając jego częstość występowania, mimo że pacjent nie spełnia kryteriów diagnozy.4

Ponadto, u dzieci astma jest często niedodiagnozowana i często błędnie diagnozowana jako przewlekłe lub nawracające zapalenie oskrzeli.5

Zmienność genetyczna i nadzór nad wirusowym zapaleniem oskrzeli

W kontekście zapalenia oskrzeli u drobiu, wirusowe zapalenie oskrzeli (IBV) stanowi znaczące zagrożenie dla hodowli na całym świecie, wymagając solidnych strategii nadzoru i szczepień. Mutacja i rekombinacja są zaangażowane w genetyczne i fenotypowe warianty wirusów RNA, prowadząc do pojawienia się nowych szczepów wariantowych.1

Sekwencjonowanie nukleotydów i późniejsza analiza genetyczna sekwencji genów białek S1 i N zapewniają szybką i dokładną metodę klasyfikacji i przewidywania genotypu IBV oraz potężne narzędzie do monitorowania filogenetycznej i epidemiologicznej ewolucji wariantów IBV.1

Badania nadzorcze w Korei Południowej wykazały obecność pięciu genotypów (QX-like, B4-like, KM91-like, K40/09-like i 20AD17-like) IBV, przy czym genotyp QX-like był najbardziej powszechny, a genotyp 20AD17-like był nowym genotypem.2

W Brazylii badanie epidemiologiczne mające na celu identyfikację potencjalnych ucieczek wirusów szczepionkowych i ocenę utrzymywania się wirusów szczepionkowych w zaszczepionych stadach brojlerów wykazało, że 91% stad było pozytywnych na IBV.3

Ciągłe pojawianie się nowych serotypów IBV utrudniło rozwój odpowiednich programów kontroli ze względu na zmienność antygenową i niski stopień ochrony krzyżowej obserwowany wśród serotypów IBV. Podkreśla to potrzebę szybkiej i precyzyjnej diagnostyki, głównie w celu identyfikacji nowych wariantów tego czynnika wirusowego i porównania ich z istniejącymi szczepami szczepionkowymi.4

Trendy epidemiologiczne i prognozy

Analiza trendów epidemiologicznych zapalenia oskrzeli dostarcza cennych informacji dla zdrowia publicznego i praktyki klinicznej. W Stanach Zjednoczonych, od 1999 do 2018 roku, wskaźniki przewlekłego zapalenia oskrzeli zmniejszyły się średnio o 1,5 punktu procentowego rocznie.1

Weigl i wsp. odnotowali ogólny wzrost hospitalizacji z powodu infekcji dolnych dróg oddechowych (zapalenie krtani, tchawicy i oskrzeli, zapalenie oskrzeli, zapalenie oskrzeli z świszczącym oddechem, zapalenie oskrzelików, zapalenie oskrzeli i płuc, zapalenie płuc) wśród niemieckich dzieci od 1996 do 2000 roku; jest to zgodne z obserwacjami wśród dzieci ze Stanów Zjednoczonych, Wielkiej Brytanii i Szwecji.2

POChP, w tym przewlekłe zapalenie oskrzeli, wzrasta na całym świecie z powodu wzrostu palenia tytoniu i zmniejszenia śmiertelności z powodu chorób zakaźnych. W niektórych regionach powszechne stosowanie paliw z biomasy, takich jak drewno, trawy lub inne materiały organiczne, również przyczynia się do zwiększenia częstości występowania POChP. Wskaźniki śmiertelności z powodu POChP mogą być wyższe w medycznie niedostatecznie obsługiwanych narodach niż w narodach, w których opieka medyczna jest bardziej dostępna. POChP odpowiadała za 3,23 miliona zgonów na świecie w 2019 roku i jest trzecią główną przyczyną śmierci.3

Prognozowanie epidemiologii zapalenia oskrzeli wymaga regularnego monitorowania i aktualizacji danych. Epidemiologia przewlekłego zapalenia oskrzeli obejmuje historyczne i aktualne dane dotyczące puli pacjentów oraz oferuje prognozowane wartości dla przypadków występujących/incydentalnych, wraz z zdiagnozowaną i możliwą do leczenia pulą pacjentów.45

W Kalifornii badanie genotypów wirusa zapalenia oskrzeli (IBV) w latach 2012-2020 wykazało znaczną zmianę, z przejściem od dominacji szczepu California 99 (2012-2014) do szczepów Massachusetts, Connecticut i California 3099, które w latach 2019-2020 odpowiadały za większość wykrytych infekcji.6

Pandemia COVID-19 stanowiła szczególne ryzyko dla pacjentów z POChP. Wskaźnik śmiertelności dla pacjentów z POChP i COVID-19 wynosił 15% w porównaniu do 4% u osób bez POChP.3

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Acute Bronchitis | Treatment & Management | Point of Care
    https://www.statpearls.com/point-of-care/18645
    Acute bronchitis represents a common clinical presentation across various healthcare settings. In the United States, approximately 5% of individuals annually report physician-diagnosed cases of acute bronchitis. The numbers tend to peak during winter, aligning with the seasonal prevalence of respiratory viral infections like influenza and RSV, which often coincide with flu season. […] Similarly, a study conducted in the United Kingdom reported similar rates of acute bronchitis, with an incidence of 54 cases per 1000 persons. Notably, these rates exhibit variability among different age groups, with lower rates among younger men (36 per 1000) and higher rates in individuals older than 85 (225 per 1000). […] In addition, several risk factors contribute to the development of acute bronchitis, including a history of smoking, residence in polluted areas, crowded living conditions, and a prior history of asthma. Specific allergens such as pollen, perfume, and vapors can potentially trigger acute bronchitis in susceptible individuals.
  • #1 Chronic Bronchitis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK482437/
    Chronic bronchitis is 1 of the most common causes of chronic cough. However, many smokers do not seek care for their cough, and studies regarding chronic cough only reveal a 5% or less incidence of chronic bronchitis. Chronic bronchitis impacts 3% to 22% of the global population and, on average, 27% to 35% of individuals with COPD. In the United States, nearly 10 million people are affected, predominantly between the ages of 44 and 65. Interestingly, 31% of those affected are between 18 and 44. Demographic factors associated with a higher incidence of chronic bronchitis for adults are smoking, older age, increasing COPD severity, female sex, asthma, obstructive sleep apnea, and non-Hispanic Black and White populations. […] PBB is the most common cause of wet cough in children younger than 5, accounting for nearly 40% of pediatric pulmonology referrals. PBB is most prevalent in male children 2 and younger, with the median age being 1.8 to 4.8, though PBB is possible in adolescents older than 12. Risk factors for developing PBB are childcare attendance, a prior history of chronic cough, parent-reported wheezing in the preceding 12 months, household crowding, and those who are experiencing homelessness.
  • #1 Interactive Dashboard | NREVSS | CDC
    https://www.cdc.gov/nrevss/php/dashboard/index.html
    The National Respiratory and Enteric Virus Surveillance System (NREVSS) is a laboratory-based system that monitors respiratory and enteric virus activity. […] NREVSS allows for timely analysis of data to monitor viral seasons and circulation patterns. […] We anticipate that NREVSS will continue to play an important role in describing the temporal and geographic circulation patterns of respiratory and enteric viruses including changes in the typical annual circulation patterns and identifying viral outbreaks. […] NREVSS has proven to be a relatively simple and practical surveillance system that will continue to be an important part of CDC’s efforts to treat, prevent, and control respiratory and enteric viral diseases.
  • #1 Epidemiology of chronic bronchitis. [European communitieS] (Journal Article) | ETDEWEB
    https://www.osti.gov/etdeweb/biblio/5499948
    Epidemiology of chronic bronchitis. [European communitieS] […] An extensive study was carried out by the ECSC between 1970 and 1976 in all EEC member countries. […] The report is recommended to those specializing and practising in medicine. […] Compares the consequences of chronic bronchitis among workers in the steel and coal industries with those engaged in other sectors of industry. […] Discusses the significance of the study and draws conclusions from it.
  • #1 Bronchitis – Wikipedia
    https://en.wikipedia.org/wiki/Bronchitis
    Acute bronchitis is one of the most common diseases and the most common type of bronchitis. About 5% of adults are affected, and about 6% of children have at least one episode yearly. It occurs more often in the winter. More than 10 million people in the U.S. visit a healthcare provider each year for this condition, with about 70% receiving antibiotics that are mostly unnecessary. There are efforts to decrease the use of antibiotics in acute bronchitis. […] Chronic bronchitis affects about 3.422% of the general population. Individuals over 45 years of age, smokers, those that live or work in areas with high air pollution, and anybody with asthma all have a higher risk of developing chronic bronchitis. This wide range is due to the different definitions of chronic bronchitis that can be diagnosed based on signs and symptoms or the clinical diagnosis of the disorder. Chronic bronchitis tends to affect men more often than women. While the primary risk factor for chronic bronchitis is smoking, there is still a 422% chance that non-smokers can get chronic bronchitis. This might suggest other risk factors such as the inhalation of fuels, dusts, fumes and genetic factor. In the United States, in 2016, 8.6 million people were diagnosed with chronic bronchitis, and there were 518 reported deaths. Per 100,000 of population the death rate of chronic bronchitis was 0.2.
  • #1 SciELO Brazil – Molecular epidemiology and evolution of avian infectious bronchitis virus Molecular epidemiology and evolution of avian infectious bronchitis virus
    https://www.scielo.br/j/rbca/a/zTx9zZzS94SKBTtgvkQf7Bj/?lang=en
    Mutation and recombination processes are involved in the genetic and phenotypic variations of RNA viruses, leading to the emergence of new variant strains, and give rise to virus population diversity to be modeled by the host, particularly by the immune system, as occurred with infectious bronchitis virus (IBV) in chickens. […] Nucleotide sequencing and subsequent genetic analysis of the S1 and N protein gene sequences provide a fast and accurate method to classify and predict IBV genotype, and a powerful instrument to monitor phylogenetic and epidemiological evolution of IBV variants. […] Despite the use of vaccination programmes, infectious bronchitis has become a serious problem in Brazil. […] Thus, a significant number of IBV field variants have been identified circulating in the Brazilian commercial poultries between 2000 to 2006 and more recently in Argentina.
  • #1 COPD Trends Brief – Prevalence | American Lung Association
    https://www.lung.org/research/trends-in-lung-disease/copd-trends-brief/copd-prevalence
    In 2018, 9.0 million adults, or 3.6% of those ages 18 or older, had chronic bronchitis. […] From 1999 to 2018, chronic bronchitis rates decreased at an average of 1.5 percentage points per year. […] In 2022, 11.7 million people, or 4.6% of adults, reported a diagnosis of COPD (chronic obstructive pulmonary disease, chronic bronchitis, or emphysema). […] During 2007-2010, around 8.5 million adults had been diagnosed with COPD, but this may be an underdiagnosis as more than 18 million had evidence of impaired lung function consistent with COPD.
  • #2 Bronchitis – Wikipedia
    https://en.wikipedia.org/wiki/Bronchitis
    Acute bronchitis is one of the most common diseases and the most common type of bronchitis. About 5% of adults are affected, and about 6% of children have at least one episode yearly. It occurs more often in the winter. More than 10 million people in the U.S. visit a healthcare provider each year for this condition, with about 70% receiving antibiotics that are mostly unnecessary. There are efforts to decrease the use of antibiotics in acute bronchitis. […] Chronic bronchitis affects about 3.422% of the general population. Individuals over 45 years of age, smokers, those that live or work in areas with high air pollution, and anybody with asthma all have a higher risk of developing chronic bronchitis. This wide range is due to the different definitions of chronic bronchitis that can be diagnosed based on signs and symptoms or the clinical diagnosis of the disorder. Chronic bronchitis tends to affect men more often than women. While the primary risk factor for chronic bronchitis is smoking, there is still a 422% chance that non-smokers can get chronic bronchitis. This might suggest other risk factors such as the inhalation of fuels, dusts, fumes and genetic factor. In the United States, in 2016, 8.6 million people were diagnosed with chronic bronchitis, and there were 518 reported deaths. Per 100,000 of population the death rate of chronic bronchitis was 0.2.
  • #2 Acute bronchitis epidemiology and demographics – wikidoc
    https://www.wikidoc.org/index.php/Acute_bronchitis_epidemiology_and_demographics
    Acute bronchitis, as a lower respiratory tract infection, is one of the most common illnesses seen among outpatient visits especially in young children. […] Acute bronchitis affects approximately 5% of adults in the U.S. annually and it becomes more common during cold seasons. Generally, it depends on the season of the year, vaccination status and presence of an epidemic. […] Acute bronchitis affects around 44 in 1000 adults (age over 16 years) per year in the UK, with around 82% of episodes occurring in autumn or winter. […] Acute bronchitis is most common among young children. […] Acute bronchitis affects men and women equally. […] There is no racial predilection for acute bronchitis.
  • #2 COPD Trends Brief – Prevalence | American Lung Association
    https://www.lung.org/research/trends-in-lung-disease/copd-trends-brief/copd-prevalence
    In 2018, 9.0 million adults, or 3.6% of those ages 18 or older, had chronic bronchitis. […] From 1999 to 2018, chronic bronchitis rates decreased at an average of 1.5 percentage points per year. […] In 2022, 11.7 million people, or 4.6% of adults, reported a diagnosis of COPD (chronic obstructive pulmonary disease, chronic bronchitis, or emphysema). […] During 2007-2010, around 8.5 million adults had been diagnosed with COPD, but this may be an underdiagnosis as more than 18 million had evidence of impaired lung function consistent with COPD.
  • #2 Acute bronchiolitis or bronchitis daily number of emergency department attendances 7 day moving average | UKHSA data dashboard
    https://ukhsa-dashboard.data.gov.uk/metrics-documentation/acute-bronchiolitis-or-bronchitis-daily-number-of-emergency-department-attendances-7-day-moving-average
    Monitoring trends in daily emergency department attendances can provide an early warning of human public health threats and provide detail to inform public health action. […] The metric shows the 7-day moving average of the daily number of attendances at emergency departments by people diagnosed with acute bronchiolitis or bronchitis in emergency departments across England. […] Acute bronchiolitis or bronchitis emergency department attendances are identified from the primary diagnosis of each attendance. […] The acute bronchiolitis or bronchitis indicator includes only acute bronchiolitis or bronchitis diagnoses, which are also included in the broader acute respiratory infections indicator. […] The data presented are based on a national syndromic surveillance system. They should be used to monitor trends, not estimate numbers of 'cases’ of a disease or condition.
  • #2
    https://link.springer.com/article/10.1007/BF00158781
    A questionnaire of respiratory symptoms and diseases completed by 6610 adults in 3 age cohorts (3536 y; 5051 y and 6566 y) in northern Sweden was followed-up by interview and lung function testing of 1243 subjects with asthmatic or bronchitic symptoms and 263 subjects assessed from the postal questionnaire as being healthy. We report the results of this follow-up study. […] According to the criteria used, 292 subjects (5.1% of the original study sample) were diagnosed as having asthma. Out of the 1243 subjects 334 (5.9% of the original study population) were diagnosed as having chronic bronchitis. […] However, examination of the 263 subjects who were healthy according to the postal questionnaire showed that elderly smokers, in particular, under-reported bronchitic symptoms; taking this into account, the prevalence of chronic bronchitis is estimated to be of the order of 9%. […] We consider that trained nurses provide reliable data that may be used in epidemiological surveys of obstructive lung diseases.
  • #2 Improving antibiotic prescribing for acute bronchitis in the ambulatory setting using a multifaceted approach | Infection Control & Hospital Epidemiology | Cambridge Core
    https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/improving-antibiotic-prescribing-for-acute-bronchitis-in-the-ambulatory-setting-using-a-multifaceted-approach/7874DA2A54DD10605A1AF331A944F72B
    Antibiotics are frequently prescribed inappropriately for acute respiratory infections in the outpatient setting. […] We report the implementation of a multifaceted outpatient antimicrobial stewardship initiative resulting in a 12.3% absolute reduction of antibiotic prescribing for acute bronchitis in primary care clinics receiving active interventions.
  • #2 Nationwide Surveillance for Infectious Bronchitis Virus in South Korea from 2020 to 2021
    https://bioone.org/journals/avian-diseases/volume-66/issue-2/aviandiseases-D-21-00118/Nationwide-Surveillance-for-Infectious-Bronchitis-Virus-in-South-Korea-from/10.1637/aviandiseases-D-21-00118.full
    Nationwide surveillance in South Korea was performed to determine the prevalence and distribution of IBV and its genotypes. […] A total of 939 samples were collected and tested for IBV detection by pathogen-specific reverse transcriptasePCR. […] A total of 114 IBV strains were isolated; 34 (30.9%) of the 110 samples obtained by passive surveillance, and 80 (9.7%) of the 829 samples obtained by active surveillance, were positive. […] Five genotypes (QX-like, B4-like, KM91-like, K40/09-like, and 20AD17-like) were observed in South Korea, with the QX-like genotype being the most common, and the 20AD17-like genotype being a novel genotype. […] These findings will help to maximize protection against IBV infection by providing a reference for the selection of an avian vaccine for IBV in South Korea.
  • #2 Pediatric Bronchitis: Practice Essentials, Pathophysiology, Etiology
    https://emedicine.medscape.com/article/1001332-overview
    Weigl et al noted an overall increase in hospitalization for lower respiratory tract infection (laryngotracheobronchitis, bronchitis, wheezing bronchitis, bronchiolitis, bronchopneumonia, pneumonia) among German children from 1996 to 2000; this is consistent with observations among children from the United States, United Kingdom, and Sweden. […] The incidence rate of bronchitis in children in this German cohort was 28%. […] A study by Berhane et al indicated that as a result of improvements in ambient air quality in Southern California, bronchitic symptoms decreased in that regions children between 1993 and 2012. […] Differences in population prevalences have been identified in patients with chronic bronchitis. […] For example, because of the association of chronic bronchitis with asthma and the concentration of asthma risk factors among inner-city populations, this population group is at higher risk.
  • #3 Respiratory Airway Infections: Bronchitis and Bronchiolitis
    https://www.atsu.edu/faculty/chamberlain/website/lectures/lecture/reairin2.htm
    Epidemiology […] Acute bronchitis usually occurs after a previous upper respiratory tract infection with extension of the infection to the bronchial tree. […] It is most common in the winter months, similar to most other respiratory diseases. […] Air pollution increases the number of cases of bronchitis. […] Acute bronchitis is a self-limiting disease in healthy adults and resolves within 710 days. […] Predisposing factors for the development of acute bronchitis in children include poor nutrition, allergy, deficiencies in IgG2, IgG3, and IgG4 subclasses, and rickets. […] Older patients who have emphysema or chronic respiratory disease (e.g., tuberculosis) are more likely to develop acute bronchitis. […] Epidemiology […] The incidence of bronchiolitis parallels respiratory infections in older children and adults and is most common during fall and winter months. […] Although infection with respiratory syncytial virus may occur at any age, the clinical disease bronchiolitis develops only in infants and young children. […] About 75% of cases of bronchiolitis occur in children younger than 1 year of age and 95% occur in children younger than 2 years of age, with a peak incidence at 28 months of age. […] The infection is usually self-limiting. […] Bronchiolitis is an acute viral infection with a favorable outcome; fatalities rarely occur. […] About 95% of children aged 2 have serologic evidence of past infection with respiratory syncytial virus; the presence of antibodies to this virus does not confer immunity. […] Risk factors include: age younger than 6 months, bottle feeding, prematurity (born before 37 weeks gestation), exposure to cigarette smoke, and crowded living conditions. […] The virus is transmitted from person-to-person by direct contact with nasal secretions or by airborne droplets. […] The risk of RSV lower respiratory tract infection (bronchiolitis) was 10 times higher for children who had older siblings, high parental educational levels, birth weights of 4 kg, attended day care, and were born between April and September, compared with children without these factors.
  • #3 Bronchitis: Practice Essentials, Background, Pathophysiology
    https://emedicine.medscape.com/article/297108-overview
    According to estimates from national interviews taken by the National Center for Health Statistics in 2006, approximately 9.5 million people, or 4% of the population, were diagnosed with chronic bronchitis. These statistics may underestimate the prevalence of chronic obstructive pulmonary disease by as much as 50%, because many patients underreport their symptoms, and their conditions remain undiagnosed. […] An overdiagnosis of chronic bronchitis by patients and clinicians has also been suggested, however. The term bronchitis is often used as a common descriptor for a nonspecific and self-limited cough, thereby falsely increasing its incidence even though the patient does not meet the criteria for diagnosis. […] In one study, acute bronchitis affected 44 of 1000 adults annually, and 82% of episodes occurred in fall or winter.
  • #3 Epidemiology and Management of Dust Mite Induced Bronchitis in Urban India | ClinicSearch
    https://www.clinicsearchonline.org/article/epidemiology-and-management-of-dust-mite-induced-bronchitis-in-urban-india
    Bronchitis is an inflammation of the airways leading into our lungs. When our trachea and bronchi get irritated, they swell up and fill with mucus, causing people to cough. Cough is the main symptom of bronchitis lasting days to a couple of weeks. While Viruses are the most common cause of acute bronchitis, in the months from October 2023 Indian cities are saddled with Bronchitis cases mainly due to dust, Smoke, smog, and other irritants in the environment. […] Air pollution is a significant worldwide health concern due to its impact on respiratory health. Air pollution caused by various pollutants in the air including PM, NO2, SO2, O3, CO, and VOCs. These pollutants harm the respiratory system by causing irritation, inflammation, damage to airways and lung tissues. They can also trigger asthma attacks and worsen existing respiratory conditions. In the last decade these dust allergic cases dont get triggered in specific seasons but are seen round the year.
  • #3 India Study on Epidemiology of Asthma, Respiratory Symptoms and Chronic Bronchitis (INSEARCH) 2007-2009 | GHDx
    https://ghdx.healthdata.org/record/india-study-epidemiology-asthma-respiratory-symptoms-and-chronic-bronchitis-insearch-2007
    The Indian Study on Epidemiology of Asthma, Respiratory Symptoms and Chronic Bronchitis (INSEARCH) was conducted in two phases. Phase II, which took place in 2007-2009, involved a survey conducted across twelve study centers throughout India. A total sample of 169,575 individuals were interviewed as part of this survey; participants were drawn from rural and urban areas for all centers except at Secunderbad, which only included urban areas. […] The questionnaire collected information about participants’ respiratory symptoms, tobacco use, exposure to secondhand smoke, cooking fuels used in the household, asthma diagnoses, and BCG vaccination history.
  • #3 Acute Bronchitis | AAFP
    https://www.aafp.org/afp/980315ap/hueston.html?page=29
    One reason that acute bronchitis is such a common diagnosis in primary care practice is that physicians often lump various conditions together under the diagnosis of bronchitis. In the absence of clear diagnostic signs or laboratory tests, the diagnosis of acute bronchitis is purely clinical. Consequently, cough from upper respiratory tract infections, sinusitis or allergic syndromes (e.g., mild asthma or viral pneumonia) may be diagnosed as acute bronchitis. […] The findings of these studies suggest that patients with acute bronchitis may have an underlying predisposition to bronchial reactivity during times of viral infection and that this reactivity may evolve into the more chronic bronchial inflammation which characterizes asthma. Recent epidemiologic findings of serologic evidence of C. pneumoniae infection in adults with new-onset asthma suggest that untreated chlamydial infections may have a role in the transition from the acute inflammation of bronchitis to the chronic inflammatory changes of asthma.
  • #3 Infectious Bronchitis Virus (IBV) in Vaccinated and Non-Vaccinated Broilers in Brazil: Surveillance and Persistence of Vaccine Viruses
    https://www.mdpi.com/2076-2607/13/3/521
    Infectious bronchitis virus (IBV) poses a significant threat to poultry worldwide, necessitating robust surveillance and vaccination strategies. This study aimed to conduct IBV surveillance in Brazil, assess potential vaccine viral escapes, and evaluate vaccine persistence in vaccinated broilers. A total of 1000 tracheal swabs from 100 flocks across six states were analyzed using RT-PCR. The results showed that 91% of the flocks tested positive for IBV. […] Epidemiological surveillance can help characterize which genotype or lineage is present in a particular region, evaluate possible vaccine viral escapes, and identify new wild strains of IBV. […] Therefore, this study aimed to conduct surveillance of IBV in Brazil, focusing on identifying vaccine viral escapes, and assessing the persistence of vaccine viruses in vaccinated broiler flocks. This objective aligns with addressing the challenges posed by IBV’s high genetic variability and its implications for vaccine efficacy. […] The data demonstrate a widespread occurrence of infectious bronchitis virus (IBV) in Brazil’s broiler flocks, with prolonged viral persistence observed in vaccinated birds and the presence of wild-type viruses in unvaccinated birds or those vaccinated against specific strains.
  • #3 Chronic Obstructive Pulmonary Disease (COPD) – Pulmonary Disorders – Merck Manual Professional Edition
    https://www.merckmanuals.com/professional/pulmonary-disorders/chronic-obstructive-pulmonary-disease-and-related-disorders/chronic-obstructive-pulmonary-disease-copd
    In the United States, approximately 24 million people have airflow limitation, of whom approximately 16 million have a diagnosis of COPD. COPD is a leading cause of death, resulting in approximately 140,000 deaths each year in the United States. Prevalence, incidence, and mortality rates increase with age. Prevalence is higher in females, but total mortality is similar in both sexes. COPD seems to aggregate in families independent of alpha-1 antitrypsin deficiency. […] COPD is increasing worldwide because of increases in smoking and reduction in mortality due to infectious diseases. In some regions, the widespread use of biomass fuels, such as wood, grasses, or other organic materials, also contributes to COPD prevalence. COPD mortality rates may be higher in medically underserved nations than in nations where medical care is more easily accessed. COPD accounted for 3.23 million deaths globally in 2019 and is the third leading cause of death. […] The COVID-19 pandemic posed a particular risk to patients with COPD. The mortality rate for patients with COPD and COVID-19 was 15% versus 4% in those without COPD.
  • #4 Bronchitis: Practice Essentials, Background, Pathophysiology
    https://emedicine.medscape.com/article/297108-overview
    According to estimates from national interviews taken by the National Center for Health Statistics in 2006, approximately 9.5 million people, or 4% of the population, were diagnosed with chronic bronchitis. These statistics may underestimate the prevalence of chronic obstructive pulmonary disease by as much as 50%, because many patients underreport their symptoms, and their conditions remain undiagnosed. […] An overdiagnosis of chronic bronchitis by patients and clinicians has also been suggested, however. The term bronchitis is often used as a common descriptor for a nonspecific and self-limited cough, thereby falsely increasing its incidence even though the patient does not meet the criteria for diagnosis. […] In one study, acute bronchitis affected 44 of 1000 adults annually, and 82% of episodes occurred in fall or winter.
  • #4 Chronic bronchitis epidemiology and demographics – wikidoc
    https://www.wikidoc.org/index.php/Chronic_bronchitis_epidemiology_and_demographics
    Chronic bronchitis is a part of COPD and its epidemiology is discussed as a sub-group of COPD. COPD occurs in 34 out of 1000 patients greater than 65 years old. In England, an estimated 842,100 of 50 million people have a diagnosis of COPD; translating into approximately one person in 59 receiving a diagnosis of COPD at some point in their lives. In the most socioeconomically deprived parts of the country, one in 32 people were diagnosed with COPD, compared with one in 98 in the most affluent areas. In the United States, the prevalence of COPD is approximately 1 in 20 or 5%, totaling approximately 13.5 million people in USA,[1][2] or approximately 25 million people if undiagnosed cases are included. […] Chronic bronchitis occurs in old ages especially in persons over 65 years old. […] Hispanics were less likely to report COPD than non-Hispanic whites and blacks (4.0% compared with 6.3% and 6.1%, respectively). Chronic bronchitis mortality rates are higher among whites than among blacks or persons of all other races. […] Women were more likely to report COPD than men (6.7% compared to 5.2%). Age adjusted death rates of men have decreased between 1999 and 2014 but this rate was stable among women.
  • #4 Epidemiology and Management of Dust Mite Induced Bronchitis in Urban India | ClinicSearch
    https://www.clinicsearchonline.org/article/epidemiology-and-management-of-dust-mite-induced-bronchitis-in-urban-india
    India has the dubious distinction of having 7 of the top 10 cities with severe or dangerous air pollution worldwide, China, Nepal, Pakistan contributing one each. While 4 of them have dangerous AQI (2 in India), rest are declared as severely polluted. […] Come winter months of November to February every year Family physicians, Pulmonologists clinics are flooded with respiratory tract Infection cases and half of them are secondary to dust mite allergy. Most of such cases come from households living near the roads with high traffic volume and high concentration of dust particles in the air and other from households living near construction sites. Primary symptoms include incessant sneezing, blocked nose, rhinitis, a bad dry cough without infections and signs include acute exacerbation of non-obstructive chronic Bronchitis due to dust irritation. About 75-80% of the allergic cases are attributed to dust mites.
  • #4 SciELO Brazil – Molecular epidemiology and evolution of avian infectious bronchitis virus Molecular epidemiology and evolution of avian infectious bronchitis virus
    https://www.scielo.br/j/rbca/a/zTx9zZzS94SKBTtgvkQf7Bj/?lang=en
    The continuous emergence of new IBV serotypes has hampered the development of appropriate control programs due to antigenic variation and the low degree of cross-protection observed among IBV serotypes. […] This emphasizes the need for prompt and precise diagnosis, mainly to identify new variants of this viral agent and to compare them with the existing vaccine strains. […] Nucleotide sequencing, followed by phylogenetic analysis of S1 protein gene sequences, offers a rapid and accurate method to identify the IBV genotype, as well as to predict IBV serotype, thereby contributing to evaluate phylogenetic and epidemiological evolution of IBV strains. […] It was demonstrated that mutation and recombination processes are involved in IBV genetic variation and subsequent evolution by a mechanism that leads to the emergence of new variant strains and the generation of virus population diversity.
  • #4 Chronic Bronchitis: Market Assessment, Epidemiology & Market Forecast-2028
    https://www.cmaxinsight.com/report-detail.php?report=CIPMA0329
    CmaxInsights Chronic Bronchitis: Market Assessment, Epidemiology Market Forecast-2028 report provides an overview of the disease and market size of Chronic Bronchitis for the seven major markets i.e., United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. […] The Report covers epidemiology of Chronic Bronchitis from 2016 to 2028 segmented by seven major markets market along with market drivers, market barriers and unmet medical needs of this indication. […] This section of the report provides the country-specific information of historical and current patient pool and offers forecasted value for prevalent/ incident cases, along with diagnosed and treatable patient pool. […] The report provides detailed historical and forecasted epidemiological data of Chronic Bronchitis in the 7MM from 2016-2028.
  • #5 Bronchitis: Practice Essentials, Background, Pathophysiology
    https://emedicine.medscape.com/article/297108-overview
    Acute bronchitis is common throughout the world and is one of the top 5 reasons for seeking medical care in countries that collect such data. No difference in racial distribution is reported, though bronchitis occurs more frequently in populations with a low socioeconomic status and in people who live in urban and highly industrialized areas. […] In terms of gender-specific incidence, bronchitis affects males more than females. In the United States, up to two thirds of men and one fourth of women have emphysema at death. Although found in all age groups, acute bronchitis is most frequently diagnosed in children younger than 5 years, whereas chronic bronchitis is more prevalent in people older than 50 years.
  • #5 Epidemiology and Management of Dust Mite Induced Bronchitis in Urban India | ClinicSearch
    https://www.clinicsearchonline.org/article/epidemiology-and-management-of-dust-mite-induced-bronchitis-in-urban-india
    As air pollution continues to wreak havoc on citizens health, staying indoors, avoiding early morning walks, getting vaccinated for flu and pneumonia, wearing N-95 mask while venturing out could help reduce adverse effects of air pollution. […] According to Head of the Department of Pulmonology at AIIMS, there has been a 10-15% increase in the number of patients with worsening symptoms over what is normally the case this year. In the last few days, there has been an exponential rise in patients with acute attacks of Bronchitis, asthma and chronic obstructive pulmonary disease (COPD) at PSRI Institute of Pulmonary, Critical care and Sleep Medicine. […] Most Pulmonologists report having not witnessed air quality as poor as it is in 2023. Most of the patients are suffering from prolonged cough and severe wheezing, with some still coughing persistently even after receiving treatment.
  • #5 Pediatric Bronchitis: Practice Essentials, Pathophysiology, Etiology
    https://emedicine.medscape.com/article/1001332-overview
    Data collected from the National Ambulatory Care Survey 1991 Summary showed that 2,774,000 office visits by children younger than 15 years resulted in a diagnosis of bronchitis. […] Although the report did not separate diagnoses into acute and chronic bronchitis, the frequency of visits made bronchitis just slightly less common than otitis media and slightly more common than asthma. […] However, in children, asthma is often underdiagnosed and is frequently misdiagnosed as chronic or recurrent bronchitis. […] Since 1996, 9-14 million Americans have been diagnosed with chronic bronchitis annually. […] Bronchitis, both acute and chronic, is prevalent throughout the world and is one of the top 5 reasons for childhood physician visits in countries that track such data. […] The incidence of bronchitis in British schoolchildren is reported to be 20.7%.
  • #5 Chronic Bronchitis – Market Insight, Epidemiology, and Market Forecast – 2034
    https://www.giiresearch.com/report/del1506623-chronic-bronchitis-market-insight-epidemiology.html
    The Chronic Bronchitis epidemiology division provide insights about historical and current Chronic Bronchitis patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken. […] The disease epidemiology covered in the report provides historical as well as forecasted Chronic Bronchitis epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2020 to 2034. […] The epidemiology segment also provides the Chronic Bronchitis epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
  • #6 Acute bronchitis – Wikipedia
    https://en.wikipedia.org/wiki/Acute_bronchitis
    Acute bronchitis is one of the most common diseases. About 5% of adults are affected and about 6% of children have at least one episode a year. It occurs more often in the winter. […] In infants under one year of age, acute bronchitis was the most common reason for admission to the hospital after an emergency department visit in the US in 2011.
  • #6 Pediatric Bronchitis: Practice Essentials, Pathophysiology, Etiology
    https://emedicine.medscape.com/article/1001332-overview
    Weigl et al noted an overall increase in hospitalization for lower respiratory tract infection (laryngotracheobronchitis, bronchitis, wheezing bronchitis, bronchiolitis, bronchopneumonia, pneumonia) among German children from 1996 to 2000; this is consistent with observations among children from the United States, United Kingdom, and Sweden. […] The incidence rate of bronchitis in children in this German cohort was 28%. […] A study by Berhane et al indicated that as a result of improvements in ambient air quality in Southern California, bronchitic symptoms decreased in that regions children between 1993 and 2012. […] Differences in population prevalences have been identified in patients with chronic bronchitis. […] For example, because of the association of chronic bronchitis with asthma and the concentration of asthma risk factors among inner-city populations, this population group is at higher risk.
  • #6 California surveillance reveals genetic and seasonal changes in infectious bronchitis virus – Poultry Producer
    https://www.poultryproducer.com/california-surveillance-reveals-genetic-and-seasonal-changes-in-infectious-bronchitis-virus/
    Genotypes of infectious bronchitis virus (IBV) found in California between 2012 and 2020 have seen a major shift, according to a study investigating patterns of IBV in the state. […] Although surveillance has been carried out in California for years, few studies have looked at patterns of IBV detection over time, explained Patrick Montine, an epidemiology PhD student at UCDavis School of Veterinary Medicine. […] The investigation into 8 years of data revealed that while the California 99 strain of IBV was most prevalent between 2012-2014, by 2019-2020, Massachusetts, Connecticut and California 3099 strains accounted for most of the infections detected through active surveillance. […] IBV is a highly variable virus, so knowing the predominant genotypes affecting each geographical region is crucial, allowing scientists to work on preparedness, vaccine schedules and combinations that can protect against new variants and reduce shedding, Montine told the 2021 Western Poultry Disease Conference.
  • #7 Acute bronchitis | Radiology Reference Article | Radiopaedia.org
    https://radiopaedia.org/articles/acute-bronchitis?lang=us
    Acute bronchitis can affect people of all ages, but it is commonest in children, especially those under the age of 3 years. It is often associated with the common cold, a sore throat and/or flu. […] Chest radiographs are not routinely indicated in cases of simple acute bronchitis. Indications for chest x-rays in adult patients with acute bronchitis are primarily to evaluate for pneumonia and include 1: […] Treatment is supportive, consisting of analgesia and sometimes bronchodilators 2.
  • #8 Pediatric Bronchitis: Practice Essentials, Pathophysiology, Etiology
    https://emedicine.medscape.com/article/1001332-overview
    Data collected from the National Ambulatory Care Survey 1991 Summary showed that 2,774,000 office visits by children younger than 15 years resulted in a diagnosis of bronchitis. […] Although the report did not separate diagnoses into acute and chronic bronchitis, the frequency of visits made bronchitis just slightly less common than otitis media and slightly more common than asthma. […] However, in children, asthma is often underdiagnosed and is frequently misdiagnosed as chronic or recurrent bronchitis. […] Since 1996, 9-14 million Americans have been diagnosed with chronic bronchitis annually. […] Bronchitis, both acute and chronic, is prevalent throughout the world and is one of the top 5 reasons for childhood physician visits in countries that track such data. […] The incidence of bronchitis in British schoolchildren is reported to be 20.7%.
  • #9 Pediatric Bronchitis: Practice Essentials, Pathophysiology, Etiology
    https://emedicine.medscape.com/article/1001332-overview
    The incidence of acute bronchitis is equal in males and females. […] The incidence of chronic bronchitis is difficult to state precisely because of the lack of definitive diagnostic criteria and the considerable overlap with asthma. […] However, in recent years, the prevalence of chronic bronchitis has been reported to be consistently higher in females than in males. […] Acute (typically wheezy) bronchitis occurs most commonly in children younger than 2 years, with another peak seen in children aged 9-15 years. […] Chronic bronchitis affects people of all ages but is more prevalent in persons older than 45 years.